U.S. cannabinoid-based pharmaceuticals market size 2020-2029 projection

On the assumption that the federal prohibition on cannabis ends by 2020, the value of the consumer market for cannabinoid-based pharmaceuticals in the United States is forecast to grow to 25 billion U.S. dollars in 2025 and be worth 50 billion U.S. dollars in 2029.

The therapeutic potential of cannabinoids

Cannabis – also known as marijuana – contains active ingredients called cannabinoids. The second-most abundant cannabinoid found in cannabis is cannabidiol (CBD), a chemical substance that is considered to have a broad range of medical benefits. Clinical trials to test the effects of cannabis-based drugs are ongoing, but potential treatments have been identified for cancer pain, glaucoma, and epilepsy. Annual sales of CBD products in the United States were expected to generate around three million U.S. dollars in 2019, with sales from the state of California contributing a 25 percent share.

Medical marijuana laws by state

In 1996, California became the first state in the United States to allow the medical use of cannabis. As of 2018, the market for medical marijuana in the United States had grown to 33 states and Washington D.C. – the state of Oklahoma had the fastest-growing medical marijuana market in the country. More states may loosen their marijuana laws over the next few years, but for the time being, cannabis remains federally illegal in the United States.

Projected cannabinoid-based pharmaceuticals market size in the U.S. from 2020 to 2029 (in billion U.S. dollars)*

Exclusive Premium statistic

You need a Single Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Single Account

only $59 / month *
in the first 12 months
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Source

Release date

February 2016

Region

United States

Survey time period

as of 2016

Supplementary notes

* Estimates assume an end to federal prohibition in the year 2020.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Single Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 / Month *
Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract; Prices do not include sales tax.

Statistics on "U.S. pharmaceutical industry"

Further Content: You might find this interesting as well

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.